Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Lonza Group AG. (3/9/17). "Press Release: Dr. Jordan Petkov Joins Lonza Consumer Care as Global Head of Research and Technology". Allendale, NJ.

Region Region ALL
Organisations Organisation Lonza (Group)
  Organisation 2 Unilever plc
  Group Unilever (Group)
Product Product  cosmetics & detergents
Persons Person Petkov, Jordan (Lonza 201703– Global Head of Research + Technology at Lonza Consumer Care before KLK POleo + Unilever)
  Person 2 Ward, Constance (Lonza 201610 Head External Communications)
     


Jordan Petkov, Ph.D., has joined Lonza Consumer Care as Global Head of Research and Technology for its Personal Care and Hygiene businesses.

Based in Blackley (UK), Dr. Petkov provides technical support for Lonza’s portfolio of hygiene, preservation, hair and skin care products. In addition, he oversees Lonza’s expansion into new personal care market sectors and strengthens Lonza’s offering in its areas of expertise.

Dr. Petkov is a 15-year veteran of the chemical process industry. Prior to joining Lonza, Dr. Petkov served for two years as a Global Research & Development Director for KLK Oleo in Petaling Jaya, Selangor (MY). He began his career as a Science Area Leader for Unilever at the Research & Development Centre in Port Sunlight (UK).

Dr. Petkov earned his Ph.D. in chemical physics and his M.S. degree in chemistry and physics at Sofia University in Sofia (BG). A Fellow of the Royal Society of Chemistry, Dr. Petkov has co-authored 95 papers and has 15 patents registered or pending. He is a Visiting Professor at the School of Physics and Astronomy, Manchester University in Manchester (UK) and at the Centre of Bioengineering and Biotechnologies, China University of Petroleum in Qingdao, Shandong (CN).


About Lonza Consumer Care – Personal Care

Part of Lonza’s Consumer Care business unit, the Personal Care business has long been the world’s leading supplier of active antidandruff agents, with its Zinc Omadine® product considered the gold standard in the antidandruff shampoo market. Lonza Personal Care also supplies a wide array of other hair- and skin-care products, including biotechnology-derived active ingredients, preservatives for use in certified natural and organic products, specialty esters and other functional ingredients. More information can be found at www.lonza.com/personalcare.


About Lonza

Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. It harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life.

Not only is Lonza a custom manufacturer and developer, the company also offers services and products ranging from active pharmaceutical ingredients to drinking water sanitizers, from nutritional and personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.

Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with approximately 40 major manufacturing and R&D facilities and more than 10,000 full-time employees worldwide. The company generated sales of CHF 4.13 billion in 2016 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.


Lonza Contact Information

Donna Weinstock
Global Marketing Communications
Lonza Consumer Care – Personal Care Lonza Group Ltd.
Tel: 201 316 9415
donna.weinstock@lonza.com

Constance Ward
Head, External Communications
Tel: +41 61 316 8840
constance.ward@lonza.com


Additional Information and Disclaimer

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.


Consumer Care
Lonza Inc.
90 Boroline Road
US-Allendale, NJ 07401
www.lonza.com Press Release


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Lonza (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Cardiovascular Health in Berlin-Brandenburg 650x300px




» top